<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="219229">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00230308</url>
  </required_header>
  <id_info>
    <org_study_id>ENT0008</org_study_id>
    <secondary_id>76537</secondary_id>
    <secondary_id>ENT0008</secondary_id>
    <secondary_id>11402</secondary_id>
    <nct_id>NCT00230308</nct_id>
  </id_info>
  <brief_title>Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer</brief_title>
  <official_title>Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through this study, we hope to learn more about the mechanisms, which may contribute to
      development and progression of head and neck cancer. The long-term goal of this study will
      be to develop new strategies and drugs for the diagnosis and treatment of head and neck
      cancer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2002</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Head and Neck Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      At the time of biospy or surgery, a small amount of tumor tissue (approximately 1 cc) will
      be taken from the main tumor specimen and stored until analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing surgery at Stanford University for head and neck cancer.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients undergoing surgery at Stanford University for head and neck cancer.

        Exclusion Criteria:

        Non-Stanford patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Quynh-Thu Le</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nikita Bedi</last_name>
    <phone>650-723-5957</phone>
    <email>nbedi@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikita Bedi</last_name>
      <phone>650-723-5957</phone>
      <email>nbedi@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Cancer Clinical Trials Office</last_name>
      <phone>(650) 498-7061</phone>
    </contact_backup>
    <investigator>
      <last_name>Quynh-Thu Le</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Willard E Fee Jr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zijie Sun</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan Matthijs van de Rijn</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr Michael Kaplan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 8, 2016</lastchanged_date>
  <firstreceived_date>September 28, 2005</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Head and Neck Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
